The valuation of the global inhalation anesthesia market was USD 1.46 billion in 2022, and it is projected to grow at a CAGR of 9.04% from 2023 to 2030.

The growth of the market can be attributed to the rise in surgical procedures and the demand for shorter hospital stays. Inhalation anesthesia offers improved patient outcomes when compared to the intravenous route. Delivering anesthetic agents through the respiratory tract allows for controlled and effective sedation, proving to be cost-effective and safe. The advantages of the inhalation route over the intravenous route serve as significant growth drivers for the market. Inhalation anesthesia is especially beneficial for patients requiring ventilation for more than 24 hours, enabling easy health monitoring.

Download Free Sample Report- https://www.marketdigits.com/request/sample/736